Doctor's Data Inc

SARS-CoV-2 RT-PCR assay

Doctor’s Data, Inc., in partnership with Kashi Clinical Laboratories, is pleased to announce the immediate availability of PCR testing of samples for SARS-COV-2 (COVID-19.) We will accept saliva samples or nasopharyngeal (NP) swab samples for testing. More information on sample collection criteria can be found here.

Price

$100 for testing. Testing fees can be paid with test submission by the patient, billed to Medicare, private insurance, or the physician’s account. Saliva collection kits sold separately. Sign into your Doctor's Data account, then click here to purchase.

How to Get Started

  1. Practitioners must have a Doctor’s Data account to order testing or to send samples to the lab. If you do not have an account, create one here.
  2. Practitioners may purchase saliva kits from Doctor’s Data for $29.00 which includes US express shipping to and from the collection site. (US only, not currently available in the state of New York.) This fee is separate from the cost of the analysis and is not covered by or billable to Medicare or private insurance. Kits are not returnable and shipping costs are non-refundable. Sign in to your Doctor’s Data account, then click here to purchase or call Customer Service at 800.323.2784.
  3. Practitioners can purchase saliva collection materials directly from the manufacturer, and send the specimen to Doctor’s Data for testing (not currently available in the state of New York)
  4. NP swab collection: Due to supply chain shortages, facilities must provide their own collection materials, patient identifiers and shipping* to Doctor’s Data. (not currently available in the state of New York) For more information, click here.
  5. More information about the test, including sample reports, collection instructions, requisition form, fact sheets, collection criteria and more can be found here.

*Shipping

Specimens must be packaged, shipped, and transported according to the current edition of the International Air Transport Association (IATA) Dangerous Goods Regulation. Follow shipping regulations for UN 3373 Biological Substance, Category B when sending potential SARS-CoV-2 specimens. Alternatively, specimen transportation guidelines from CDC for SARS-CoV-2 specimens can be followed. (https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html)

This test has not been FDA cleared or approved. This LDT test has been authorized by FDA under an Emergency Use Authorization (EUA). This test has been validated in accordance with the FDA's Guidance Document (Policy for Diagnostics Testing in Laboratories Certified to Perform High Complexity Testing under CLIA prior to Emergency Use Authorization for Coronavirus Disease-2019 during the Public Health Emergency) issued on February 29th, 2020. FDA independent review of this validation is pending. Samples should be collected in a healthcare setting with a practitioner present to supervise collection.

Please visit this page for other important updates specific to COVID-19 and your Doctor’s Data account.

SARS-CoV-2 (COVID-19)

Gastrointestinal Health

Toxic and Essential Elements

Nutritional

Environmental Exposure and Detoxification

Cardiovascular

SARS-CoV-2 (COVID-19)

Blood Spot

Endocrinology